Data / Form D filings / Nodal Therapeutics, Inc.
Nodal Therapeutics, Inc.: Form D filings
Nodal Therapeutics, Inc., a pharmaceuticals company in Silver Spring, MD, filed 2 Form D notices with the SEC in 2024. The latest, on October 29, 2024, reports $250,000 sold of a $250,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1804 EDGEWATER PARKWAY, Silver Spring, MD, 20903
- Phone
- (608) 215-5779
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2024197
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Amendment | $250,000 | $250,000 | 1 | May 23, 2024 | sec.gov | |
| Jun 6, 2024 | New notice | $100,000 | $100,000 | 1 | May 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan S. Bromberg | Executive Officer | |
| Christopher Jewell | Executive Officer, Director |
Other pharmaceuticals companies in Maryland that filed recently
- Cerium Pharmaceuticals, Inc. $750,000 · Aug 6, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Nodal Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.